argyrotsipi/train-dataset huggingface dataset:
Glasgow School of Art — House of Commons, 2018-06-19
Topic: Culture
David Gordon Mundell (Conservative, Centre-right): I am sure that every effort will be made, because the School of Art has a world-class fundraising operation. It has alumni around the world and, indeed, campuses around the world—for example, I had the pleasure to visit the campus in Singapore. We stand ready to help and support the School of Art in any of those efforts, but one thing that the experience over the past four years has demonstrated is its skill and ability in respect of fundraising.
Glasgow School of Art — House of Commons, 2018-06-19
Topic: Culture
David Gordon Mundell (Conservative, Centre-right): The hon. Lady ends her question with a very good sentiment, and I echo it fully. The School of Art has been able to draw on worldwide expertise and to develop and see through skills that were not previously exercised, and it stands in a good position to know what would be needed in a future restoration, although the scale of this restoration would obviously be much greater than the previous one.
Cannabis-based Medicines — House of Commons, 2018-06-19
Topic: Health
Crispin Jeremy Rupert Blunt (Conservative, Centre-right): I thank my right hon. Friend for his statement and the rapid way in which he has gripped this issue. As co-chair of the all-party parliamentary group for drug policy reform, let me say that this is a very welcome step forward. There is a substantial amount of medical evidence out there, including a 2016 paper on this issue—commissioned by my predecessor co-chairs of the APPG—by Professor Mike Barnes, who has been associated with the Alfie Dingley case. Will my right hon. Friend make it clear that Professor Sally Davies has been given two tasks, including one on the expert panel to advise on immediate applications for licences? Will he confirm that people will not be asked to pay the swingeing fees that were being asked of the Dingley family in respect of their licences? Finally, what is the expected timescale for the second task that my right hon. Friend has asked the chief medical officer to undertake?
Cannabis-based Medicines — House of Commons, 2018-06-19
Topic: Health
Sajid Javid (Conservative, Centre-right): I thank the hon. and learned Lady for her comments. She is right to highlight that thousands of people may be suffering. No one knows the exact number, but it is estimated that at least 10,000 children in the UK have a drug-resistant form of epilepsy. That really puts into focus what a big difference these measures can make. I can also give her an assurance about bureaucracy and hurdles. Frankly, there has been a lot of bureaucracy and many hurdles in the way until now. The decision that we made on Friday was unprecedented, as are the measures that we are putting in place. The expert panel will make a huge difference. Its whole purpose is to make the process as smooth and quick as possible, based on medical advice at all points. I do not want to prejudge the review, but I am sure that the hon. and learned Lady can sense the direction.
Cannabis-based Medicines — House of Commons, 2018-06-19
Topic: Health
Craig Mackinlay (Conservative, Centre-right): As chair of the all-party parliamentary group on cannabis: harmful effects on developing brains, I thank my right hon. Friend for his assurances that any future medicinal use of cannabis will not be conflated with any weakening of the Government’s position on recreational use. Is he aware of the increasingly clear evidence of permanent psychosis and depression among young people who are users of what we see on our streets more regularly—skunk cannabis?
Cannabis-based Medicines — House of Commons, 2018-06-19
Topic: Health
Sajid Javid (Conservative, Centre-right): I am very much aware of that. It is perfectly correct for my hon. Friend to highlight this point. As I made clear in my statement and I am happy to make absolutely clear again, there are no plans at all to decriminalise cannabis. It is a controlled class B drug under the Misuse of Drugs Act 1971, and that will not change.
Cannabis-based Medicines — House of Commons, 2018-06-19
Topic: Health
Sajid Javid (Conservative, Centre-right): The right hon. Lady makes a number of good points. She is right to highlight that there are currently drugs that are under schedule 2, meaning that the medical benefits are accepted, but which can be a lot more harmful than other drugs if they are used in the wrong way. She asked about the role of the Department of Health and Social Care in these kinds of decisions. This requires a cross-Government approach, with the Home Office and the Department of Health and Social Care working closely together, as we have seen. We have an issue in that these drugs are categorised as illegal under the Misuse of Drugs Act, but we need to recognise, where appropriate, that some of them have medicinal benefits, as has already been recognised with, for example, cocaine and morphine. It is therefore appropriate that the two Departments work together.
Cannabis-based Medicines — House of Commons, 2018-06-19
Topic: Health
Richard Grosvenor Plunkett-Ernle-Erle-Drax (Conservative, Centre-right): I absolutely understand the Government’s review of this policy, and I welcome it for those who suffer and need this drug to make them better, but may I just say that, from my own life experience, I am delighted that the Government are not going to decriminalise the use of drugs. All too often, people start on cannabis and end on something far worse, and I have personally seen the devastation to families and the loss of children because of drugs.
Cannabis-based Medicines — House of Commons, 2018-06-19
Topic: Health
Sajid Javid (Conservative, Centre-right): Yes, I think that there is a need to make the process clearer. I have been quite open that I do not think that the current process is a friendly one at all. The decision made in the case of Billy Caldwell was unprecedented; no Government in the past had recognised the medicinal benefits of cannabis by making such a decision and issuing a licence. We need to make the process—even the interim process, through the expert panel—much smoother and more straightforward. Once the panel is set up, which will happen by next week, we will set out exactly how the process will work for the hon. Lady’s constituents and others.
Cannabis-based Medicines — House of Commons, 2018-06-19
Topic: Health
Sajid Javid (Conservative, Centre-right): This is about making sure that the best possible medical treatment is available for everyone in the UK, but especially our children. It is about medical treatment, not the recreational use of drugs, which can cause severe damage to people. I am afraid that I do not agree with the right hon. Gentleman on that point, and nor, on this occasion, do I agree with Lord Hague.
Cannabis-based Medicines — House of Commons, 2018-06-19
Topic: Health
Simon James Hoare (Conservative, Centre-right): I thank my right hon. Friend for very much humanising this issue. As chairman of the all-party group on multiple sclerosis, I welcome his announcement about the medical aspect of cannabis. May I offer the services of the MS Society in any inquiry and call for evidence that he might have? May I also associate myself with his remarks about drugs? I am frankly staggered that my right hon. and noble Friend Lord Hague—or indeed anybody else—could advocate such a thing. We will all have seen at first hand in our constituencies the devastation that cannabis causes. This is not recreational use—it steals lives and futures, and we must be robust in ensuring that it stops.
Cannabis-based Medicines — House of Commons, 2018-06-19
Topic: Health
Sajid Javid (Conservative, Centre-right): My hon. Friend is absolutely right on that point. He will know that Sativex, which has a cannabis base, is already licensed for those with MS, but today’s announcement is about how we can improve on the medical use of cannabis even further.
Cannabis-based Medicines — House of Commons, 2018-06-19
Topic: Health
Sajid Javid (Conservative, Centre-right): Let me say gently to the hon. Lady that in the case of Alfie Dingley, of course we are all pleased that we have been able to issue the licence today. She should know that before the application—the approach by his clinicians—no Government had even entertained the idea, given that cannabis is classed as a schedule 1 drug, of looking at this from a medical point of view. This Government have done that. I hope that she can join us in not just welcoming that, but working together on how we can end the suffering of so many other people, particularly children, who could benefit from these kinds of medicines.
Cannabis-based Medicines — House of Commons, 2018-06-19
Topic: Health
Philip Thomas Hollobone (Conservative, Centre-right): I commend the Home Secretary for his statement. I support the legalisation of cannabis for medical use. May I urge him to encourage the clinical review team to get on with it? There is already a mass of internationally accredited research available that they can draw on, so we do not need to reinvent the wheel. The research is there—it just needs to be studied and then a decision can be made quickly.
Cannabis-based Medicines — House of Commons, 2018-06-19
Topic: Health
Sajid Javid (Conservative, Centre-right): My hon. Friend makes a good point. One of the issues has been that our rules in this area have not kept up with medical research and evidence. At least 13 European countries, as well as Canada and over 30 US states, have recognised the medicinal benefits of cannabis. The World Health Organisation has also done work on this and pointed to evidence. We will be using and drawing on all that evidence. That is why I am pleased that Professor Sally Davies has said that she can complete her work in days.
Cannabis-based Medicines — House of Commons, 2018-06-19
Topic: Health
Sajid Javid (Conservative, Centre-right): Yes, it is. It has an important role to play, which is to advise Ministers on the scheduling of drugs. If we are to change a scheduling, it is important to listen to its point of view.
Cannabis-based Medicines — House of Commons, 2018-06-19
Topic: Health
Michael James Tomlinson-Mynors (Conservative, Centre-right): I welcome the fact that the Home Secretary set out at the start of his statement that "cannabis can harm people’s mental and physical health and damage communities." I also welcome the fact that any change will be science-led. Will he also look at international examples? He mentioned Canada, where a law was introduced very recently. Will he see what works—and, importantly, what does not work—with that law, in particular, because the evidence is mixed?
Cannabis-based Medicines — House of Commons, 2018-06-19
Topic: Health
Henry Edward Millar Smith (Conservative, Centre-right): I have long advocated the use of medical cannabis and therefore very much welcome the Home Secretary’s announcement of a review. May I have assurances that that review will be very much patient-centred and led by evidence of how the use of medical cannabis can help those with chronic conditions?
Cannabis-based Medicines — House of Commons, 2018-06-19
Topic: Health
Sajid Javid (Conservative, Centre-right): First, Sativex was looked at for a particular condition. It is right that drugs are looked at the context of the condition that they are intended to help with. The hon. Gentleman makes a good wider point about whether, once the review is complete, we can get on with it, with any changes made quickly. That is exactly what I intend to do.
Cannabis-based Medicines — House of Commons, 2018-06-19
Topic: Health
David James Duguid (Conservative, Centre-right): As chairman of the all-party group on 22q11.2 deletion syndrome, I know many parents of children who have a rare genetic condition that often goes undiagnosed and, when diagnosed, is not always appropriately treated. From that experience, I am sure that Billy’s family welcome today’s statement. I welcome the fact that elements of the statement show that the Government look to the evidence and respond to the public interest, as well as that of the patient at the forefront.
Cannabis-based Medicines — House of Commons, 2018-06-19
Topic: Health
Sajid Javid (Conservative, Centre-right): My hon. Friend is right. The process should absolutely be clinically led. We should listen to evidence from clinicians while drawing on international evidence, too. That is exactly what should feed into the outcome of the review.
Cannabis-based Medicines — House of Commons, 2018-06-19
Topic: Health
Sajid Javid (Conservative, Centre-right): As the rules stand, until the review is complete and changes are made, any use of cannabis for medicinal purposes will require a Home Office licence or, in the case of Northern Ireland, a licence from the Health Department there. I hope that what I have set out today has given reassurance that I recognise the need for action now, not tomorrow or in a few weeks or months. We need action now, and that is the purpose of the expert panel—to make this a much smooth, quick and clinically-led process.
Cannabis-based Medicines — House of Commons, 2018-06-19
Topic: Health
Sajid Javid (Conservative, Centre-right): Under the current rules, those are not recognised. To be a bit clearer, all drugs that may or may not have a medicinal benefit are scheduled, and drugs in schedule 1, which is where cannabis is at the moment, are not recognised to have medicinal benefits under the law. That said, we of course want to look at the evidence, and to be led by evidence and clinicians, which was exactly why I made today’s announcement and why I took action last week.
Parliamentary Constituencies (Amendment) Bill: Committee Stage — House of Commons, 2018-06-19
Topic: Health
Robert Goodwill (Conservative, Centre-right): I was elected on a manifesto that called for a reduction in the number of MPs to 600. How can I look my constituents in the eye and spend the equivalent of 600 nurses’ salaries on something for which they did not vote?
Complex Regional Pain Syndrome — House of Commons, 2018-06-19
Topic: Health
Alexander John Gervase Chalk (Conservative, Centre-right): The hon. Lady, through her constituent’s experience, is painting a vivid picture of the pain. Does she agree that hearing accounts such as that of my constituent Helena Stone—she said it was like barbed wire being tightened across one’s leg—give an insight into the viciousness of this debilitating condition and make it all the more important that we raise awareness of it?
Complex Regional Pain Syndrome — House of Commons, 2018-06-19
Topic: Health
Alexander John Gervase Chalk (Conservative, Centre-right): The hon. Lady is being extremely generous in giving way. My constituent experienced the problem of not being believed. Does the hon. Lady agree it is all the more galling that the NHS website recognises the condition and states that it is "poorly understood"? Does that not make the point that the situation needs to change?
Complex Regional Pain Syndrome — House of Commons, 2018-06-19
Topic: Health
Caroline Julia Dinenage (Conservative, Centre-right): I will certainly look at that The hon. Lady mentioned delays in referral to a pain clinic, which is something that concerns me. Waiting times should be about 13 weeks once a GP has referred someone, but, as she says, some people wait longer. NHS England commissions the highly specialised pain management services for adults and children, and we will raise the issue with it. The National Institute for Health and Care Excellence has also published guidance for the pharmacological management of neuropathic pain, which includes CRPS. The guidance was updated earlier this year to reflect the latest available evidence Patients with CRPS will usually be managed through routine access to primary or secondary care. For patients with the most chronic and intractable pain, a referral can be made to a highly specialised pain service, commissioned by NHS England. Here, patients can receive multidisciplinary expert care and specialised treatment. Once diagnosed, patients can expect access to a range of other healthcare professionals for support and on-going treatment. This includes physiotherapists, occupational therapists, neurologists, a psychologist to help with the associated psychological problems caused by living with CRPS, and other healthcare professionals trained in pain relief The hon. Lady spoke about research. The National Institute for Health Research welcomes research funding applications for any aspect of human health, including CRPS. The CRPS UK clinical and research network was established in 2006. It is a research collaboration between a number of UK NHS trusts and academic institutions with an interest in the disorder. Its primary aim is to raise awareness and understanding among health professionals, patients and the general public. This year it is 10 years since the network established the CRPS registry, which now holds over 500 records and contributions and has contributed to seven different national and international research studies I thank the hon. Lady again for bringing this important debate to the House. I have attempted to answer as many of her questions as I can, but I will come back to her with anything that I have not covered. I hope that the debate has been helpful in raising the profile of this very difficult and distressing condition Question put and agreed to.
Devolved Government — House of Commons, 2018-10-31
Topic: Health
Andrew William Murrison (Conservative, Centre-right): If the Executive are not restored by the end of the year, will the Secretary of State use the powers she is about to get under the Northern Ireland (Executive Formation and Exercise of Functions) Bill to issue guidance to ensure that Northern Ireland gets a proper cancer strategy, since it is the only part of the UK that does not have one, and I am afraid that outcomes are reflecting that?
Devolved Government — House of Commons, 2018-10-31
Topic: Health
Karen Anne Bradley (Conservative, Centre-right): My hon. Friend, who served as a Minister in the Northern Ireland Office and is Chair of the Select Committee, understands the devolution settlement and constitutional arrangements better than many people. He will know that it will be for Ministers to make the decision on the implementation of the cancer strategy, but clearly the guidance that accompanies the Bill will be issued after Royal Assent, and I would hope that civil servants will take the decisions that they can take within that guidance.
Legacy Consultation — House of Commons, 2018-10-31
Topic: Defense
Sheryll Murray (Conservative, Centre-right): The witch hunt against our brave veterans is unacceptable. My constituent, who lives opposite the surgery where I used to work, has reportedly refused much-needed medical treatment so that he can get to court. Many will not forgive us, and nor should they, if he is lost due to disease once this case continues. When will the Government stop consulting and bring an end to these ridiculous cases?
Legacy Consultation — House of Commons, 2018-10-31
Topic: Defense
Julian Murray Lewis (Conservative, Centre-right): Does the Secretary of State accept that someone must cut the Gordian knot that is preventing us from ensuring that our armed forces veterans are not persecuted and pursued in the courts decades after they have faithfully served us?
Engagements — House of Commons, 2018-10-31
Topic: Health
Questions: May I welcome what my right hon. Friend said about Armistice Day? That will be welcomed by the 1st Battalion, The Rifles, who are based in my constituency.The Prime Minister will know that the tax burden is approaching a 50-year high and that we do not help families with the cost of living by raising their taxes, so I am really pleased that we kept our promise to cut taxes for 32 million people. May I ask her to make sure that as the economy grows we continue both to cut taxes and to spend money on our priorities in a balanced way that works for everyone in our country?; CLIC Sargent, a wonderful cancer charity for children, has found that families in Harlow face a 54-mile round trip to get to their nearest treatment location, costing them up to £161.58 per month. Average families taking their children for cancer treatment are paying £180 per month. Given the huge £20 billion increase in the NHS budget, will my right hon. Friend meet me and CLIC Sargent, and introduce a young cancer travel fund to help those families with the cost of living?
Theresa Mary May (Conservative, Centre-right): I thank my right hon. Friend for his question. He raises a very important issue. Obviously, our thoughts are with those children and their families at what must be a really difficult time for both the children and their families. We continue to look at what we can do to help them. I believe that when he talks about children from his constituency going to the nearest specialist treatment centre, that is Great Ormond Street, which does wonderful work in this country for children. We have a healthcare travel cost scheme that allows patients to receive reimbursement for their travel costs if they are in receipt of a qualifying benefit and on a low income, but we absolutely recognise that there is more to do, particularly on the cost of living for cancer patients, including children and young people, as my right hon. Friend said. I know that the relevant Minister from the Department of Health and Social Care will be very pleased to meet him and the charity to discuss that further.
Budget Resolutions — House of Commons, 2018-10-31
Topic: Health
Victoria Grace Ford (Conservative, Centre-right): This morning, leaders in genomics met in the House of Commons. They are world leaders based in Britain, and they told us how cures and treatments are being delivered to patients in the NHS today. Does my right hon. Friend agree that it is this Government’s investment in science and research that has led to us being a world leader in this area?
Budget Resolutions — House of Commons, 2018-10-31
Topic: Defense
Richard Grosvenor Plunkett-Ernle-Erle-Drax (Conservative, Centre-right): I will leave the politics to the Scottish National party, but what I will say is that I agree that more money is needed for the defence of our country; there is no doubt about that. We need more sailors. We have two aircraft carriers, but can probably only afford to man one. Aircraft carriers need submarines underneath, aircraft on top, and ships beside; they are the biggest expense budget item we could possibly have. I ask the Treasury please not to forget our brave men and women of the armed services. I have another minute—thanks very much to the SNP, and I am sorry that those on the Opposition Benches will regret it—so let me end on the topic of home affordability, as it is a key issue. We all talk about affordable homes, but they are not; 80% of market value is not affordable. I say to the Government that we must think about how we can provide homes that are truly affordable to those, particularly in my constituency, who simply cannot afford to buy them at current prices. Radical review of that is necessary, please.
UK Tourism — House of Commons, 2018-09-06
Topic: Culture
Craig Paul Tracey (Conservative, Centre-right): May I also welcome my right hon. and learned Friend to his place? As a fellow Warwickshire MP, he is obviously very aware of the draw that our local area brings. Unfortunately, many miss the opportunity to see the north of the county and the hidden gems up there, such as Middleton hall, our historic towns and the beautiful rural countryside, instead concentrating more on the south of the county. What role can Government initiatives such as the cultural development fund play in helping these lesser known tourist attractions in the north to fully realise their potential?